BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7480868)

  • 1. Preoperative concomitant radiochemotherapy and IORT in locally advanced rectal cancer.
    Crucitti F; Sofo L; Ratto C; Battista Doglietto G; Bellantone R; Nucera P; Bossola M; Ranieri R; Perilli W; Azario L
    Rays; 1995; 20(2):197-207. PubMed ID: 7480868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality therapy of resectable high risk rectal cancer.
    Picciocchi A; Coco C; Magistrelli P; Cogliandolo S; Carbone L; Cosimelli M; Impiombato FA; Vecchio FM; De Santis M; Mantini G
    Rays; 1995; 20(2):182-9. PubMed ID: 7480866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
    ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
    Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy results of locoregional recurrences in rectal cancer].
    Böhm B; Helfritzsch H; Thiele M; Altendorf-Hofmann A; Scheele J
    Zentralbl Chir; 2001 Aug; 126(8):596-601. PubMed ID: 11518998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative radiotherapy and IORT in resectable rectal cancer at high risk for local recurrence.
    Crucitti F; Ratto C; Sofo L; Battista Doglietto G; Bellantone R; Bossola M; Sollazzi L; Crea MA; Vecchio FM; Piermattei A
    Rays; 1995; 20(2):190-6. PubMed ID: 7480867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
    Pfeiffer P
    Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients.
    Klug C; Wutzl A; Kermer C; Voracek M; Kornek G; Selzer E; Glaser C; Poeschl PW; Millesi W; Ewers R
    Int J Oral Maxillofac Surg; 2005 Mar; 34(2):143-8. PubMed ID: 15695042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
    Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
    Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy and local control in rectal cancer.
    Valentini V; Rosetto ME; Fares C; Mantini G; Salvi G; Turriziani A
    Rays; 1998; 23(3):580-5. PubMed ID: 9932477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor downstaging through preoperative chemoradiotherapy in locally advanced rectal cancer].
    Liang H; Schlag PM
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):77-9. PubMed ID: 11977647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy in rectal cancer: stage of the disease and therapeutic approach.
    Cellini N; Valentini V; Barbaro B; Marano P
    Rays; 1995; 20(2):132-44. PubMed ID: 7480862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraoperative radiotherapy (IORT) in the treatment of rectal cancer].
    Doglietto GB; Ratto C; Valentini V
    Ann Ital Chir; 2001; 72(5):567-71. PubMed ID: 11975411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative radiation therapy (IORT) in primary locally advanced and recurrent carcinoma of the rectum at a "non-dedicated" facility.
    Hesselmann S; Micke O; Bruewer M; Ochman S; Senninger N; Willich N; Schaefer U
    Anticancer Res; 2003; 23(2C):1875-81. PubMed ID: 12820472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.